Mesoblast | MSB - Selling And Administration Expenses

Stock Price
2.49
Daily Change
0.02 0.81%
Monthly
-9.78%
Yearly
-21.94%
Q1 Forecast
2.48

Mesoblast reported $18.85M in Selling and Administration Expenses for its fiscal semester ending in June of 2025.





Selling And Administration Expenses Change Date
Avita Medical AUD 20.98M 253K Jun/2025
Clinuvel Pharmaceuticals AUD 9.12M 6.2M Jun/2025
Cochlear AUD 234.95M 235.05M Jun/2025
CSL USD 727M 453M Jun/2025
Pacific Edge NZD 19.17M 1.32M Dec/2025
Paradigm Biopharmaceuticals AUD 1.61M 747.79K Jun/2025
PYC Therapeutics AUD 2.13M 447.24K Jun/2025
Ramsay Health Care AUD 5.29B 3.2M Dec/2024
Sonic Healthcare AUD 2.52B 2.46B Dec/2024
Starpharma Holdings AUD 1.56M 1.57M Jun/2025
Telix Pharmaceuticals AUD 55.91M 31.78M Dec/2024